Literature DB >> 32258789

The impact of folic acid supplementation on gestational and long term health: Critical temporal windows, benefits and risks.

Carla Silva1, Elisa Keating2,3, Elisabete Pinto4,5.   

Abstract

HIGHLIGHTS: Associations between FA supplementation in pregnancy and effects on offspring's NTDs, allergy/respiratory problems, cancer and behaviour problems as been studied.There is growing concern about the effects of excessive FA supplementation, whether in terms of doses or times of exposure.FA supplementation in the periconceptional period is protective against NTDs while in later periods it could be deleterious.A daily dose of 0.4 mg FA in the periconceptional period seems to be effective and safe. ABSTRACT: Maternal folic acid (FA) supplementation is one of the most popular nutritional interventions during pregnancy for its protective effect against neural tube defects (NTDs).The purposes of this review are: (a) to gather the current evidence regarding supplementation of maternal diet with FA and (b) to problematize the available literature in terms of dosages, critical temporal windows, and its potential benefits and risks.The expression (pregnancy OR fetus OR offspring OR mother) AND ("folic acid" AND supplementation) was searched on PubMed database, filtering for articles published from 2005 to 2014. Publications referring to FA supplementation during the periconceptional period or pregnancy in which there was a conclusion about the effects of isolated FA supplementation on pregnant woman, pregnancy or offspring were included. Of the initial 1182 papers, 109 fulfilled the inclusion criteria.The majority of the publications reported FA supplementation outcomes on offspring's health, with emphasis in NTDs, allergy/respiratory problems, cancer and behaviour problems. Some inconsistency is observed on the impact of FA supplementation on different outcomes, except for NTDs. It is also visible an increased concern about the impact of excessive supplementation, either in terms of doses or exposure's duration.In conclusion, there is a growing interest in FA supplementation issues. The protective effect of FA supplementation over NTDs has been confirmed, being the periconceptional period a critical window, and it is frequently suggested that allergy/respiratory outcomes arise from (excessive) FA supplementation particularly later in pregnancy. Further research on critical doses and time of exposure should be conducted. Copyright 2017 PBJ-Associação Porto Biomedical/Porto Biomedical Society.

Entities:  

Keywords:  Folic acid; Offspring; Periconceptional; Pregnancy; Supplementation

Year:  2017        PMID: 32258789      PMCID: PMC6806748          DOI: 10.1016/j.pbj.2017.05.006

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN: 2444-8664


  122 in total

1.  Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the offspring.

Authors:  Karen K Y Sie; Alan Medline; Jacobine van Weel; Kyoung-Jin Sohn; Sang-Woon Choi; Ruth Croxford; Young-In Kim
Journal:  Gut       Date:  2011-05-11       Impact factor: 23.059

2.  Prenatal exposure to medicines and the risk of childhood brain tumor.

Authors:  Karin Stålberg; Bengt Haglund; Bo Strömberg; Helle Kieler
Journal:  Cancer Epidemiol       Date:  2010-05-26       Impact factor: 2.984

3.  Association of microtia with maternal obesity and periconceptional folic acid use.

Authors:  Chen Ma; Suzan L Carmichael; Angela E Scheuerle; Mark A Canfield; Gary M Shaw
Journal:  Am J Med Genet A       Date:  2010-11       Impact factor: 2.802

4.  Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study.

Authors:  Anna M Rozendaal; Anthonie J van Essen; Gerard J te Meerman; Marian K Bakker; Jan J van der Biezen; Sieneke M Goorhuis-Brouwer; Christl Vermeij-Keers; Hermien E K de Walle
Journal:  Eur J Epidemiol       Date:  2013-10-04       Impact factor: 8.082

5.  Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study.

Authors:  A E Czeizel; E H Puhó; Z Langmar; N Acs; F Bánhidy
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-11-17       Impact factor: 2.435

6.  Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project.

Authors:  NaTasha D Hollis; Emily G Allen; Tiffany Renee Oliver; Stuart W Tinker; Charlotte Druschel; Charlotte A Hobbs; Leslie A O'Leary; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Sallie B Freeman; Stephanie L Sherman; Lora J H Bean
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

7.  Gene expression profiling in the fetal cardiac tissue after folate and low-dose trichloroethylene exposure.

Authors:  Patricia T Caldwell; Ann Manziello; Jamie Howard; Brittany Palbykin; Raymond B Runyan; Ornella Selmin
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-02

8.  Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8-year-old children in rural Nepal.

Authors:  Christine P Stewart; Parul Christian; Kerry J Schulze; Steven C Leclerq; Keith P West; Subarna K Khatry
Journal:  J Nutr       Date:  2009-06-23       Impact factor: 4.798

9.  Effects of altered maternal folic acid, vitamin B12 and docosahexaenoic acid on placental global DNA methylation patterns in Wistar rats.

Authors:  Asmita Kulkarni; Kamini Dangat; Anvita Kale; Pratiksha Sable; Preeti Chavan-Gautam; Sadhana Joshi
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

10.  Antenatal risk factors for peanut allergy in children.

Authors:  Karen E Binkley; Chad Leaver; Joel G Ray
Journal:  Allergy Asthma Clin Immunol       Date:  2011-10-04       Impact factor: 3.406

View more
  1 in total

1.  High-dose folic acid supplementation results in significant accumulation of unmetabolized homocysteine, leading to severe oxidative stress in Caenorhabditis elegans.

Authors:  Kyohei Koseki; Yukina Maekawa; Tomohiro Bito; Yukinori Yabuta; Fumio Watanabe
Journal:  Redox Biol       Date:  2020-09-15       Impact factor: 11.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.